Machiavelli Capital

The interest of each is the good of all

[Machiavelli Capital @MachiavelliCap]

@HYcorps @WShak1 Buy 18 to 24 months of equity optionality for Stroll and friends if the turnaround + specials deliver

[Machiavelli Capital @MachiavelliCap]

@MoneyMinersMill @ArbLens 1) Sadiola is more than half of company’s NAV twice the LoM of Kurmuk
2) Rarely you have a 25-30% move in gold in 6 months to closing, plus close a deal at all time highs of gold price after a 40% move in the previous 9 months

[Machiavelli Capital @MachiavelliCap]

@MoneyMinersMill @ArbLens Mali deteriorating fast, gold down 25%. China has the upper hand here clearly, look where this trades if the deal falls through you get 25-27 per share vs 36-40 if you renegotiate. Win win

[Machiavelli Capital @MachiavelliCap]

@HYcorps @NHS Proper third world country

[Machiavelli Capital @MachiavelliCap]

@HowardBlowsNKTR @seedy19tron 80%+ of his stake are options with a strike of $58 + sales were planned so have to go through even w takeover talks ongoing

[Machiavelli Capital @MachiavelliCap]

@seedy19tron + Robin has a large tranche of performance options that vest specifically on the Phase 3 event

[Machiavelli Capital @MachiavelliCap]

$NKTR can’t catch a bid lol

[Machiavelli Capital @MachiavelliCap]

@absreturnchaser I think it’s because the value of the freeholds is not enough to cover the shitty going concern part of the biz

[Machiavelli Capital @MachiavelliCap]

@absreturnchaser Why did 3 funds walk away in the last 18 months tho?

[Machiavelli Capital @MachiavelliCap]

@RayneWothbaum what's the price

[Machiavelli Capital @MachiavelliCap]

New $NKTR CFO:
She was most recently the Chief Financial Officer of Adverum Biotechnologies, Inc. from 2022 through its sale to Eli Lilly and Company in 2025

Interesting track record, settlement or sale with $LLY?

[Machiavelli Capital @MachiavelliCap]

@RayneWothbaum Expanding to the bigger picture a takeover doesn't make sense to you? The guy is 73 with 4 years ahead for commercialization. LLY saves a few mills + gets AA optionality AD 2-L + some preclinical stuff given they like to pay $bn for shitcos

[Machiavelli Capital @MachiavelliCap]

@RayneWothbaum I've followed enough cases to know even settlement numbers like $500m or $1bn are usually inflated. I also know building narratives in front of jury is powerful: *admission* of stat test miscal + Dermira acquisition + return rights for free + emails could move the needle

[Machiavelli Capital @MachiavelliCap]

@RayneWothbaum I mean this CFO is just a random hire, just funny this is the first line of her description in the NKTR 8K
Ofc this is unrelated to the settlement, but this lawsuit has a clear winner if you put LLY emails in front of a jury. So it would make sense to buy it

[Machiavelli Capital @MachiavelliCap]

Also, the CEO is 73...

[Machiavelli Capital @MachiavelliCap]

@ESGhound Where could be the marginal selling coming from to break this

[Machiavelli Capital @MachiavelliCap]

@anchovycapital @2147mill Lawrence will continue to bail this out

[THE SHORT BEAR @TheShortBear]

https://t.co/lwliIOZEnY

[Machiavelli Capital @MachiavelliCap]

@DReds928 It did hit hard indeed!